Try our beta test site

A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2017 by Dana-Farber Cancer Institute
Sponsor:
Information provided by (Responsible Party):
Neil Martin, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT01858688
First received: May 15, 2013
Last updated: February 7, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)